Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Ajanta Pharma posted 14% revenue growth and a 20% profit rise in Q2 FY26, and approved an interim dividend of ₹28 per share with a November record date.
India’s top 16 IT services companies returned a record ₹130,000 crore in FY26 via dividends and buybacks, even as AI disruption slowed growth and pressured valuations.
RBI will inject over ₹2,00,000 crore via a 90-day VRR, a $10 billion USD/INR swap, and ₹1,00,000 crore OMO bond purchases across late January and February 2026.
GMR Airports’ FY24 annual report outlines the NCLT-sanctioned merger, the registered office shift, a higher Delhi airport stake, and a later Rs 5,000 crore fund-raise approval.
Amber Enterprises reported FY26 consolidated revenue above ₹12,000 crore, flagged a qualified audit opinion tied to unaudited entities, and set an earnings call for May 18, 2026.
Craftsman Automation reported record FY26 revenue of ₹8,069 crore and 91% YoY PAT growth, while the board also signalled dividends, restructuring steps, and fresh fund-raising plans.
Shriram Asset Management Company has scheduled a May 15, 2026 board meeting to consider FY26 audited results, following recent postal-ballot approvals, ESOP allotments, and continued quarterly losses.
Gautam Adani and Sagar Adani agreed to pay $18 million to settle US SEC claims tied to Adani Green disclosures, with the deal still awaiting court approval.
With petrol and diesel up ₹3 per litre and Brent near $110, FMCG makers such as HUL, Dabur and Marico are weighing more price hikes and grammage cuts.
With crude priced in dollars, a weak rupee and high oil can widen India’s deficits, lift imported inflation, and complicate choices for the government and RBI.
Fusion Finance has seen sharp price swings across 2024-2026 after a June 2024 quarterly loss and higher provisioning, alongside mixed analyst ratings and targets.
CuraTeQ Biologics, Aurobindo Pharma’s subsidiary, received Health Canada’s Notice of Compliance for Bevqolva, a bevacizumab biosimilar for multiple cancer indications, enabling marketing authorisation.
Social media is focused on how crude above $110 and a stronger US dollar could lift inflation, widen the CAD, pressure the rupee, and squeeze growth.
Supreme Holdings & Hospitality will meet on May 15, 2026 to approve audited standalone and consolidated Q4 and FY26 results and take auditors’ reports on record.
Social media and news chatter shows Nifty sentiment turning risk-off as US-Iran war headlines push crude near $100-$105, raising inflation worries and volatility expectations.
JSW Dulux reported a 360% jump in FY26 consolidated PAT to ₹1,973.8 crore on exceptional gains from divestments, even as revenue fell and dividend rose to ₹206 per share.